Skip to main content

New Products

  • Vivus submits sNDA in support of a shorter efficacy window for its ED medicine Stendra

    MOUNTAIN VIEW, Calif. — Vivus and Auxilium Pharmaceuticals on Tuesday announced that the Food and Drug Administration has accepted a supplemental application that proposes to revise the Stendra (avanafil) prescribing information with efficacy and safety information from Study TA-501, entitled "A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men with Erectile Dysfunction." 

    The PDUFA date for the supplemental filing is Sept. 20, 2014.

  • Bic Soleil Glow razor hits shelves

    SHELTON, Conn. — Bic Consumer Products has broadened its portfolio of razors with the new Bic Soleil Glow, which started hitting retail shelves this month.

  • Dunkin' Donuts, WhiteWave Foods bring new creamers to grocery stores

    CANTON, Mass. — Dunkin' Donuts and WhiteWave Foods on Tuesday announced an agreement to bring Dunkin' Donuts Coffee Creamers to grocery stores and club stores nationwide.

    WhiteWave Foods, a consumer packaged food and beverage company, will develop, manufacture and distribute the creamers which are sold in 32-oz, quart-sized bottles and come in four varieties: Original, Fat-Free, Extra Extra and Unsweetened.  

  • Jelly Belly to introduce beer-flavored bean

    FAIRFIELD, Calif. — Jelly Belly Candy Company is set to unveil a new flavor to its collection: the Draft Beer Jelly Belly jelly bean. Jelly Belly will debut the new flavor at the Winter Fancy Food Show in San Francisco and ISM in Cologne, Germany. The beer flavor has been a popular request by consumers for decades, the company said. 

  • Publix rolls out med sync program chainwide, powered by Ateb’s Time My Meds

    RALEIGH, N.C. — Publix Super Markets is rolling out their Time My Meds powered medication synchronization program, Sync Your Refills, to all of its pharmacy locations. 

  • FDA approves Mekinist in combination with Tafinlar to treat patients with advanced melanoma

    NEW YORK — The Food and Drug Administration recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (i.e., cannot be removed by surgery) or metastatic (i.e., late-stage), Onco360 announced last week. 

    Both Mekinist and Tafinlar are only available in limited distribution, and Onco360 is one of the few pharmacies with access to both medications.

  • Emmi-Tech develops new 'Nature' toothpaste

    LAS VEGAS — Emmi-Tech, the distributor of the Emmi-dent Ultrasound toothbrush, has unveiled a new gluten-free, fluoride-free and paraben-free toothpaste called Nature.

    According to the company, the new Nature toothpaste creates nano-bubbles that are imploded by the ultrasound waves of the toothbrush to remove bacteria, plaque, tartar, small food scraps and stains.

  • Quaker Oats serves up new offerings

    CHICAGO — Quaker Oats, a subsidiary of PepsiCo, is adding some innovative, energy-packed products to its lineup, the company said.

    The latest offerings from the Quaker brand include:

     

X
This ad will auto-close in 10 seconds